在体外非酒精性脂肪肝疾病中实时聚合酶连锁反应的定量参考基因
Jingzhi Chen1, Xingmi Chen2, Ying Liu2
1School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Gene
|December 3, 2025
概括
这项研究确定Ywhaz是自由脂肪酸 (FFA) 诱导的代谢功能障碍相关脂肪肝疾病 (MAFLD) 模型中定量PCR (qPCR) 最稳定的参考基因. 此外,还建立了一个可靠的选程序.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 参考基因是必不可少的,但在代谢功能障碍相关的脂肪肝疾病 (MAFLD) 研究中往往没有得到验证.
- 通过定量PCR (qPCR) 准确的基因表达分析依赖于稳定的参考基因.
研究的目的:
- 在自由脂肪酸 (FFA) 诱导的MAFLD细胞模型中识别和验证qPCR最稳定的参考基因.
- 建立一种可靠的方法来选MAFLD研究中的参考基因.
主要方法:
- RNA测序 (RNA-seq) 在对照和FFA治疗的AML12细胞上进行.
- 候选参考基因从文献中选择,并使用RNA-seq数据进行过 (双指数排名,变化系数,Log2FoldChange).
- 用多个算法 (NormFinder,BestKeeper,geNorm,ΔCt,RefFinder) 评估候选基因的表达稳定性.
主要成果:
- FFA治疗导致AML12细胞中显著的脂质滴积累.
- RNA-seq分析和RefFinder确定Ywhaz是最稳定的参考基因.
- 与其他候选人相比,Ywhaz表现出优越的表达稳定性.
结论:
- 使用AML12细胞模型,Ywhaz是使用FFA诱导的MAFLD中的qPCR最稳定的参考基因.
- 该研究提供了一种验证的程序,用于在MAFLD研究中选择参考基因.
- 这一发现支持在MAFLD中进行更准确的基因表达研究.
相关概念视频
Cell Specific Gene Expression
13.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121


